Jeuveau Injectors Near You

No. Jeuveau (prabotulinumtoxinA) and Botox (onabotulinumtoxinA) are different brands of botulinum toxin type A made by different companies. They work the same way and their unit dosing is close to 1:1, but Jeuveau is FDA-approved only for frown lines, while Botox has many approved uses.

Jeuveau, made by Evolus, is often called "Newtox" because it launched as a cosmetic-only competitor and is usually priced a little lower. Practically, patients report similar onset, about 2 to 3 days, and similar duration, about 3 to 4 months. Comparative trials suggest it performs on par with Botox for glabellar lines. The differences that matter to you are price, your injector's familiarity with it, and approved indications: Botox is also approved for crow's feet, forehead lines, chronic migraine, excessive underarm sweating, and more, whereas Jeuveau has no medical indications. Using Jeuveau on the forehead or crow's feet is legal and common but off-label. Side effects are the same class: bruising, headache, and, uncommonly, eyelid or brow droop.

Jeuveau before-and-after photos show softened frown lines (the "11s" between the brows), which is the only area Jeuveau is FDA-approved to treat. Assess them at day 14: onset is 2-3 days, full effect about two weeks, and results last 3-4 months.

Jeuveau (prabotulinumtoxinA, nicknamed "Newtox") is a cosmetic-only product with no therapeutic indications, and its approval covers glabellar lines alone; forehead and crow's feet use is off-label: legal and common. It's molecularly close to Botox and dosed roughly 1:1, with 20 units for the frown-line complex. It's often priced lower, which is much of its appeal. When reading a gallery, check that the before and after use the same expression: a frowning "before" paired with a relaxed "after" manufactures a result that isn't there. Also confirm no filler or resurfacing was done alongside. Expect softening rather than erasure: deep static lines that persist at rest need repeated cycles, and often other treatments, to improve.

Jeuveau's common side effects are headache, injection-site bruising and swelling, and occasionally a temporary droopy eyelid or brow: essentially the same profile as Botox. Most are mild and resolve within days to weeks. Jeuveau carries the FDA boxed warning for distant spread of toxin effect.

Jeuveau is prabotulinumtoxinA, structurally very close to Botox, and it behaves like it: effects appear in 2-3 days, peak at two weeks, and wear off over 3-4 months. Eyelid or brow droop occurs when product reaches the eyelid levator or over-relaxes the forehead; it isn't reversible and fades as the toxin clears, though apraclonidine drops may partially lift the lid meanwhile. Jeuveau is FDA-approved for frown lines only and has no therapeutic indications, so forehead and crow's feet treatment is off-label: legal and common. Avoid in pregnancy and breastfeeding, in neuromuscular disorders like myasthenia gravis, and if you've previously reacted to a botulinum toxin. Seek urgent care for trouble swallowing, speaking, or breathing.

Jeuveau typically costs $9 to $15 per unit in the US, usually a few dollars below Botox. A standard frown-line treatment of about 20 units runs roughly $200 to $400, and treating frown lines, forehead, and crow's feet together generally costs $350 to $700.

Jeuveau (prabotulinumtoxinA) was launched as a value-positioned competitor to Botox and is dosed unit-for-unit with it, so the per-unit comparison is direct: 20 units of Jeuveau does roughly what 20 units of Botox does. Price varies with your city, your injector's experience, and how many units your muscles require, and some clinics charge a flat fee per area instead of per unit. Always ask how many units you are receiving so you can compare clinics honestly. Jeuveau is a cosmetic-only product and is never covered by insurance. Manufacturer rewards programs and clinic loyalty pricing can lower the effective cost. These are typical 2026 ranges and vary by market rather than fixed prices.

Yes. Jeuveau (prabotulinumtoxinA) is FDA-approved and its safety profile is very similar to Botox. The most common side effects are headache, bruising, and temporary eyelid or brow droop. Like every botulinum toxin, it carries an FDA boxed warning for spread of toxin beyond the injection site.

Jeuveau was FDA-approved in 2019 for moderate-to-severe frown lines (glabellar lines) only. It has no therapeutic indications, so use on the forehead, crow's feet, or elsewhere is off-label, which is legal and routine but worth knowing. Its clinical trials showed efficacy and tolerability comparable to Botox. Side effects are almost always local and resolve in days to weeks; eyelid droop, the most bothersome, typically fades over several weeks. The boxed warning describes rare cases in which toxin spreads and causes swallowing or breathing problems, seen mainly with large therapeutic doses rather than cosmetic ones. Avoid Jeuveau if you are pregnant, breastfeeding, or have a neuromuscular disorder such as myasthenia gravis, and choose a licensed, experienced injector.